Children in the risk of metabolic syndrome
Authors:
S. Bartůňková
Authors place of work:
Univerzita Karlova v Praze, FTVS, Katedra fyziologie a biochemie
Published in the journal:
Čas. Lék. čes. 2009; 148: 584-590
Category:
Review Article
Summary
The global increase of children obesity has recently alerted top research teams. They have focused on finding causes present already in the prenatal period, on establishing diagnostic criteria for both childhood and adolescent ages, and on seeking for methods of monitoring risk and preventing metabolic syndrome manifestations. This paper is a literature review from prestigious medical journals that monitor the development of risks from the ontogenetic point of view. The paper deals not only with the issue of obesity itself, but also all risk complications like early atherosclerosis, higher blood pressure, insulin resistance, fatty liver, or sleep respiratory disorders.
Key words:
risk of obesity of children, metabolic syndrome, prevention and therapy of obesity.
Zdroje
1. Lobstein T, Bauer L, Uauy R. Obesity in children and young people: a crisis in public health. ObesRev 2004; 5 (Suppl.1): 4–8.
2. James PT, Rigby N, Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 2004; 11: 3–8.
3. Spiotta RT, Luma GB. Evaluating obesity and cardiovascular risk factors in children and adolescents Am Farm Physician 2008; 78: 1052–1058.
4. Bornstein SR, Ehrhart-Bornstein M, Wong ML, et al. Is the worldwide epidemic of obesity a communicable feature of globalization? Exp Cli Endocrinol Diabetes 2008; 116 (Suppl. 1): S30–S32.
5. Lebl J, Kytnarová J. Obezita v dětském věku. Stanovisko České lékařské akademie. Revue ČLA 2008; 4: 28–29.
6. Pařízková J, Lisá L. Obezita v dětství a dospívání. 2. doplněné a přepracované vydání. Praha: Galén 2007; 239 s.
7. Vignerová J, Bláha P. Obezita u dětí a dorostu v České republice – dlouhodobé změny, metody sledování. In: Pařízková J, Lisá L. Obezita v dětství a dospívání. 2. doplněné a přepracované vydání. Praha: Galén 2007; 27–65.
8. Cole TJ, Belizzi MC, Flegal KM, et al. Establishing a standard definition for childhood overweight and obesity world-wide: international surway. BMJ 2000; 320: 1–6.
9. Wabitsch M. Overweight and obesity in European children:definition and diagnostic procedures, risk factors and consequences for later health outcome. Eur J Pediatr 2000; 159: S2–S11.
10. WHO. Obesity, Preventing and Managing the Global Epidemic. Report of a WHO Consultation. World Health Organisation: Geneva 2000, 894.
11. Hainerová I. Genetické faktory v etiologii a patogenezi obezity. In: Pařízková J, Lisá L. Obezita v dětství a dospívání. 2. doplněné a přepracované vydání. Praha: Galén 2007; 87–106.
12. Loke KY, Lin JB, Mabel DY. 3rd College of paediatrics and child health lecture-the past, the present and the shape of things to come. Ann Acad Med Singap 2008; 37: 429–434.
13. Silveira WMF, Horta BL. Birth weight and metabolic syndrom in adults: meta-analysis. Rev Saúde Pública 2008; 42: 10–18.
14. Skidmore PM, Hardy RJ, Kuh DJ, et al. Life course body size and lipid levels at 53 years in a British birth cohort. J Epidemiol Community Health 2007; 61: 215–220.
15. Hirschler V, Bugna J, Rogue M, Gilligan T, et al. Does low birth weight predict obesity/overweight and metabolic syndrome in elementary school children? Arch Med Res 2008; 39: 796–802.
16. Woollett LA. Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation. Am J Clin Nutr 2005; 82: 1155–1161.
17. Yang XZ, Liu Y, Mi J, et al. Pre-clinical atherosclerosis evaluated by carotid artery intima-media thickness and the risk factors in children. Chin Med J 2007; 120: 359–362.
18. Thompson DR, Obarzanek E, Franko DL, et al. Childhood overweight and cardiovascular disease risk factors: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr 2007; 150: 18–25.
19. Pilz S, Horejsi R, Möller R, et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab 2005; 90: 4792–4796.
20. Schwab KO, Doerfer J, Krebs A, et al. Early atherosclerosis in childhood type 1 diabetes: role of raised systolic blood pressure in the absence of dyslipidaemia. Eur J Pediatr 2007; 166: 541–548.
21. Atabek ME, Pirgon O, Kivrak AS. Evidence for association between insulin resistance and premature carotid atherosclerosis in childhood obesity. Pediatr Res 2007; 61: 345–349.
22. Quijada Z, Paoli M, Zerpa Y, et al. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors. Pediatr Diabetes 2008; 9: 464–471.
23. Yoshinaga M, Sameshima K, Tanaka YH, et al. Adipokines and the prediction of the accumulation of cardiovascular risk factors or the presence of metabolic syndrome in elementary school children. Circ J 2008; 72: 1874–1878.
24. Yoshinaga M, Sameshima K, Tanaka Y, et al. Association between the number of cardiovascular risk factors and each risk factor level in elementary school children. Circ J 2008; 72: 1594–1597.
25. Bocca G, Stolk RP, Scheenstra R, et al. Non-alcoholic fatty liver disease in children: a new complication of obesity. Ned-Tijdschr-Geneeskd 2008; 152: 2443–2447.
26. Chiloiro M, Riezzo G, Chiarappa S, et al. Relationship among fatty liver, adipose tissue distribution and metabolic profile in moderately obese children: an ultrasonographic study. Curr Pharm Des 2008; 14: 2693–2698.
27. Li WJ, Xue H, Sun K, et al. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria. Chin Med J 2008; 121: 1532–1536.
28. Jolliffe CJ, Janssen I. Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and International Diabetes Federation criteria. J Am Coll Cardiol 2007; 49: 891–898.
29. Sinaiko AR, Steinberger J, Moran A, et al. Influence of Insulin Resistance and Body Mass Index at Age 13 on Systolic Blood Pressure, Triglycerides, and High-Density Lipoprotein Cholesterol at Age 19. Hypertension 2006; 48: 730–736.
30. Weiss R, Shaw M, Savoye M, Caprio S. Obesity dynamics and cardiovascular risk factor stability in obese adolescents. Pediatr Diabetes 2009; v tisku.
31. Alkazemi D, Egeland G, Vaya J, et al. Oxysterol as a marker of atherogenic dyslipidemia in adolescence. J Clin Endocrinol Metab 2008; 93: 4282–4289.
32. Camhi SM, Kuo KJ, Young DR. Identifying adolescent metabolic syndrome using body mass index and waist circumference. Prev Chronic Dis 2008; 5: A115.
33. Koerner A, Kratzsch J, Gausche R, et al. Metabolic syndrome in children and adolescents – risk for sleep–disordered breathing and obstructive sleep-apnoea syndrome? Arch Physiol Biochem 2008; 114: 237–243.
34. COPAT. Základní informace o projektu. Dostupné z: www.copat.cz/index.php/aktualne-o-projektu/zakladni informace-o-projektu (26. 8. 2009).
35. Flynn MTA, McNell DA, Maloff B, et al. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with “best practice” recommendations. The International Association for the study of Obesity. Obesity reviews 2006; 7 (Supp. 1): 7–66.
36. Doak CM, Visscher TLS, Renders, et al. The prevention of overweight and obesity in children and adolescents: a review of interventions and programmes. International Life Sciences Institute. Obesity reviews 2006; 7: 11–136.
37. Rosolová H. The Czech Institute of the Metabolic Syndrome. MetS insights 2005; 7: 7–8.
38. Klub metabolického syndromu. Dostupné z: www.metabolicky syndrom-klub.cz
39. Williamson DA, Martin, DO, White MA, et al. Efficiacy of an internet–based behavioural weight loss program for overweight adolescent African-American girls. Eating Weight Disorders 2005; 10: 193–203.
40. Hakanen M, Langstrom H, Kaitosaari T, et al. Development of overweight in an atherosclerosis prevention trial starting in early childhood. The STRIP study. Int J Obes (Lond) 2006; 30: 618–626.
41. Massin MM, Lebrethon MC, Rocour D, et al. Patterns of physical activity determined by heart rate monitoring among diabetic children. Arch Dis Child 2005; 90: 1223–1226.
42. Mark AE, Janssen I. Relationship between screen time and metabolic syndrome in adolescents. J Publ Health 2008; 30: 153–160.
43. American Heart Association Scientific Statement. Dietary Recommendations for Children and Adolescents. Circulation 2005; 112: 2061–2075.
44. Ding EL, Huffless SM, Ding X, et al. Chocolate and prevention of cardiovascular disease: a systemic review. Nutr Metab (Lond), 2006; 3: 2.
45. McCrindl BW, Urbina EM, Dennison BA, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 2007; 115: 1948–1967.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Assessment of health state and working capacity of people suffering from locomotive system diseases
- Children in the risk of metabolic syndrome
- Pathological gambling – a pilot study of treatment effects
- Multi-marker approach in the diagnostics of cardiac diseases by protein biochip technology